Gabelli Securities »

Cidara Therapeutics shares owned by Gabelli Securities

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Gabelli Securities from 13F filings

Historical chart of Gabelli Securities investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Gabelli Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Gabelli Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $21M 96k 220.89

More positions owned by Gabelli Securities

Dayforce Equity (DAY)
Frontier Communications Pare Equity (FYBR)
Chart Industries Equity (GTLS)
Electronic Arts Equity (EA)
Exact Sciences Corp Equity (EXAS)
Avidity Biosciences Equity (RNA)
Cidara Therapeutics Equity (CDTX)
Hologic Equity (HOLX)
Txnm Energy Equity (TXNM)
Gabelli Dividend & Income Tr Exchange Traded (GDV)
Cyberark Software Ltd/israel Equity (CYBR)
Sealed Air Corp Equity (SEE)
Confluent Inc-class A Equity (CFLT)
Gdl Fund Exchange Traded (GDL)
Norfolk Southern Corp Equity (NSC)

View all positions for Gabelli Securities

Top funds holding Cidara Therapeutics

RA Capital Management
Bain Capital Life Sciences Investors
Vanguard Group
Point72 Asset Management
BVF
Vivo Capital
BlackRock
UBS Group
Darwin Global Management
Paradigm Biocapital Advisors
VR Adviser
FMR
State Street Corporation
Citadel Advisors
Henderson Group

View all funds holding Cidara Therapeutics